Form 4 for ACXP Acurx Pharmaceuticals, Inc.
Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-19 · accession 0001104659-21-142473 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-22 | 2021-11-19 | ACXP | DELUCCIA ROBERT J | Dir, 10% | P - Purchase | $4.90 | +5,034 | 1.03M | +0.5% | +$24.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-19 | P | A | 5,034 | $4.90 | 1,031,461 | D | — | — | (F1) The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.886 to $4.961 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price. |